This website is not optimized for your browser version. Update to the latest Internet Explorer Version for a safer and faster web experience
2022 Neuromodulation Society of Australia and New Zealand

2022 Neuromodulation Society of Australia and New Zealand15th Annual Scientific Meeting (NSANZ 2022)13 - 14 August 2022 | Sofitel Melbourne on Collins, VIC

Sponsored Sessions

Saturday 13 August 2022, 7:15am - 8:15am

Unleash the power of 39141

Abbott is committed to you and your practice with patient centric solutions, powered by evidence! And now, with Australia’s first remote care technology for chronic pain patients in NeuroSphere Virtual Clinic, Abbott is leading the way in integrating digital care into your practice. Through partnership with clinician thought leaders and Department of Health, Abbott has pioneered the reimbursement for remote care. Join us as we launch the code and hear from both an international and an Australian key opinion leader on how NeuroSphere and a reimbursement for remote care can transform your practice and empower your patients.  

Meet Our Experts:

Kiran V. Patel M.D.

Dr. Patel is an Interventional Pain Management physician, board-certified in Pain Medicine and Anaesthesiology. Dr. Patel practices at the Spine & Pain Institute of New York and is the Director of Neurosurgical Pain at Lenox Hill Hospital in New York City. She is most recognized for her expertise in neuropathic pain, cancer-related pain, CRPS, pelvic pain, headache, atypical facial pain, and peripheral neuralgias. Dr. Patel is an active member of the North American Neuromodulation Society’s Board of Directors and co-chaired 2021 NANS Mid-Year meeting.

James Yu M.D. 

Dr. Yu is a board-certified Interventional Pain Specialist and Consultant Anaesthetist and is currently the Medical Director of Sydney Spine and Pain (SSP), a clinic with several multi-disciplinary pain centres across Sydney. Dr. Yu is passionate about clinical research, supporting professional education and evidence-based practice and is an Executive Board Member of the Neuromodulation Society of Australia and New Zealand (NSANZ).

Frequency Matters – The continuing evolution of High Frequency SCS

This year Nevro is celebrating 10 years of positive patient outcomes! Built on the outcomes from 100,000+ patients, HFX combines innovative technologies, advanced therapies, and end-to-end patient support to achieve the best possible results. HFXTM Nevro’s one comprehensive platform for individualized relief from chronic pain. Join Nevro’s VP of Scientific Affairs – Kerry Bradley with an overview of the development of HF SCS, a discussion on the current theories of the mechanism of action and an examination of the key milestones in achieved in clinical research.

Meet Our Expert:

Kerry Bradley, trained as an Electrical Engineer, has worked in an R&D, Clinical, and Research capacity in implantable electrical stimulation for 27 years. In the 1990s, he developed algorithms for pacemaker optimization in bradycardia and heart failure.  In the 2000's he researched and developed the patient-controlled stimulation fitting algorithms for the Precision SCS system. He also designed and participated in small-scale clinical studies for technical and parameter optimization, focusing predominantly in SCS. He joined Nevro in 2013, where he leads a research team focusing on clinical and preclinical investigations into mechanisms of action of HF10 Therapy.  He has collaborated on several peer-reviewed papers, book chapters, numerous presentations and posters in biomedical engineering, and holds over 100 patents.


Sunday 14 August 2022, 7:15am - 8:15am

Loss of Neuromuscular Control: The Problem No One is Addressing

Mainstay Medical is proud to bring you exceptional and experienced speakers discussing the pathology of neuromuscular instability due to arthogenic inhibition and motor control dysfunction of multifidus. Providing a deeper understanding of the role of multifidus as the primary intersegmental stabiliser of the lumbar spine, the cycle of pain, degeneration and dysfunction of multifidus and the resultant cortical changes that occur. Exploring the process of differentiating between the source of pain and the cause of the pain in chronic mechanical low back pain, the current treatment options for multifidus dysfunction and where restorative neurostimulation fits into this treatment algorithm. As well as discussing optimal candidate selection for restorative neurostimulation, how to identify multifidus dysfunction in clinical practice and the mechanism of action of restorative neurostimulation in this patient cohort.

Meet Our Experts:

Mr Yun-Hom Yau

Mr. Yau has specialty recognition as a Fellow of the Royal Australasian College of Surgeons in Neurosurgery and is a Fellow of the Faculty of Pain Medicine Australian and New Zealand College of Anaesthetists. He is Lead Clinician and Director of The International Spine Centre, an interdisciplinary private practice pioneering collaborative approaches to the management of spinal disorders and pain.

A/Professor Tillman Boesel

Associate Professor Boesel has held an academic appointment at Macquarie University’s Australian School of Advanced Medicine since 2007. In addition to his academic position, he currently practices at Macquarie University Hospital, Macquarie Neurosurgery, Chris O’Brien Lifehouse and Nepean Private Hospital; with private consulting in Penrith, North Ryde and Newtown.